263 related articles for article (PubMed ID: 19141711)
1. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).
Tahara H; Yee SW; Urban TJ; Hesselson S; Castro RA; Kawamoto M; Stryke D; Johns SJ; Ferrin TE; Kwok PY; Giacomini KM
J Pharmacol Exp Ther; 2009 Apr; 329(1):262-71. PubMed ID: 19141711
[TBL] [Abstract][Full Text] [Related]
2. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
[TBL] [Abstract][Full Text] [Related]
3. Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter.
Frigeni M; Iacobazzi F; Yin X; Longo N
Biochim Biophys Acta; 2016 Jun; 1860(6):1334-42. PubMed ID: 26994919
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.
Garrett Q; Xu S; Simmons PA; Vehige J; Flanagan JL; Willcox MD
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4844-9. PubMed ID: 18641280
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
Tamai I
Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations of the SLC22A5 gene in the Chinese and Indian populations of Singapore.
Toh DS; Yee JY; Koo SH; Murray M; Lee EJ
Drug Metab Pharmacokinet; 2010; 25(1):112-9. PubMed ID: 20208395
[TBL] [Abstract][Full Text] [Related]
8. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
9. Organic cation/carnitine transporter OCTN2 (SLC22A5) -207C>G (rs2631367) polymorphism is not associated with male infertility.
Droździk M; Oronowicz K; Piasecka M; Kazienko A; Rosiak A; Gill K; Dziedziejko V; Safranow K; Kurzawa R; Kurzawski M
Reprod Biol; 2015 Sep; 15(3):178-83. PubMed ID: 26370461
[TBL] [Abstract][Full Text] [Related]
10. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
Amat di San Filippo C; Wang Y; Longo N
J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha.
Maeda T; Wakasawa T; Funabashi M; Fukushi A; Fujita M; Motojima K; Tamai I
Biol Pharm Bull; 2008 Jun; 31(6):1230-6. PubMed ID: 18520060
[TBL] [Abstract][Full Text] [Related]
12. Tooth loss and adiposity: possible role of carnitine transporter (OCTN1/2) polymorphisms in women but not in men.
Meisel P; Pagels S; Grube M; Jedlitschky G; Völzke H; Kocher T
Clin Oral Investig; 2021 Feb; 25(2):701-709. PubMed ID: 32964310
[TBL] [Abstract][Full Text] [Related]
13. Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines.
Qu Q; Qu J; Zhan M; Wu LX; Zhang YW; Lou XY; Fu LJ; Zhou HH
PLoS One; 2013; 8(10):e76474. PubMed ID: 24146874
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and Organic Cation Transporters Novel (OCTNs).
Pochini L; Galluccio M; Console L; Scalise M; Eberini I; Indiveri C
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672410
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort.
Leung E; Hong J; Fraser AG; Merriman TR; Vishnu P; Krissansen GW
Immunol Cell Biol; 2006 Apr; 84(2):233-6. PubMed ID: 16519742
[TBL] [Abstract][Full Text] [Related]
16. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
17. SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
Wang C; Uray IP; Mazumdar A; Mayer JA; Brown PH
Breast Cancer Res Treat; 2012 Jul; 134(1):101-15. PubMed ID: 22212555
[TBL] [Abstract][Full Text] [Related]
18. Functional activity of L-carnitine transporters in human airway epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2016 Feb; 1858(2):210-9. PubMed ID: 26607009
[TBL] [Abstract][Full Text] [Related]
19. Expression of the organic cation/carnitine transporter family (Octn1,-2 and-3) in mdx muscle and heart: Implications for early carnitine therapy in Duchenne muscular dystrophy to improve cellular carnitine homeostasis.
Lamhonwah AM; Tein I
Clin Chim Acta; 2020 Jun; 505():92-97. PubMed ID: 32070725
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the IBD5 locus to Crohn's disease in the Swedish population.
Törkvist L; Noble CL; Lördal M; Sjöqvist U; Lindforss U; Nimmo ER; Löfberg R; Russell RK; Satsangi J
Scand J Gastroenterol; 2007 Feb; 42(2):200-6. PubMed ID: 17340776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
